SCHEMBL9309430

SCHEMBL9309430

CCc1cc(NCCN)ccc1C(=O)O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4C Q9H3R0 2/20 0.43
▸ GABRP O00591 2/20 0.41
▸ GABRD O14764 2/20 0.41
▸ GABRA1 P14867 2/20 0.41
▸ GABRB1 P18505 2/20 0.41
▸ GABRG2 P18507 2/20 0.41
▸ GABRB3 P28472 2/20 0.41
▸ GABRA5 P31644 2/20 0.41
▸ GABRA3 P34903 2/20 0.41
▸ GABRA2 P47869 2/20 0.41
▸ GABRB2 P47870 2/20 0.41
▸ GABRA4 P48169 2/20 0.41
▸ GABRE P78334 2/20 0.41
▸ GABRA6 Q16445 2/20 0.41
▸ GABRG1 Q8N1C3 2/20 0.41
▸ GABRG3 Q99928 2/20 0.41
▸ GABRQ Q9UN88 2/20 0.41
▸ MCL1 Q07820 2/20 0.40
▸ BCL2L1 Q07817 1/20 0.40
▸ ALDH1A1 P00352 4/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5025350 0.84 PLK1 (0.49) KDM4CMCL1BCL2L1MAPTPLK1
SCHEMBL11523096 0.83 ALDH1A1 (0.42) KDM4CGABRPGABRDGABRA1GABRB1
SCHEMBL524509 0.82 MCL1 (0.39) KDM4CGABRPGABRDGABRA1GABRB1
SCHEMBL1839262 0.80 MAPT (0.54) KDM4CGABRPGABRDGABRA1GABRB1
SCHEMBL9307375 0.80 GAA (0.43) KDM4CMCL1BCL2L1ALDH1A1PLK1
SCHEMBL5189869 0.79 TERT (0.52) KDM4CALDH1A1MAPTHPGDKMT2A
Hydrochloric Acid SCHEMBL8785708 0.79 MAPT (0.53) KDM4CGABRPGABRDGABRA1GABRB1
SCHEMBL8856987 0.78 GABRP (0.42) KDM4CGABRPGABRDGABRA1GABRB1
SCHEMBL11237479 0.77 PPARA (0.62) KDM4CKMT2AGAAPPARASTING1
SCHEMBL8888227 0.76 POLB (0.55) MAPTTDP1HPGDMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5352677-A Antihyperlipidemic agents KANEGAFUCHI KAGAKU KOGYO KABUSHIKI KAISHA (JP) 1994-10-04 — — US disclosed
EP-0407200-B1 Cinnamamide derivatives KANEGAFUCHI CHEMICAL IND (JP) 1994-06-01 — — EP disclosed
US-5294643-A Cinnamamide derivative KANEGAFUCHI KAGAKU KOGYO KABUSHIKI (JP) 1994-03-15 — — US disclosed
US-5294624-A Antiartheriosclerosis KANEGAFUCHI KAGAKU KOGYO KABUSHIKI KAISHA (JP) 1994-03-15 — — US disclosed
EP-0407200-A1 Cinnamamide derivatives KANEGAFUCHI KAGAKU KOGYO KABUSHIKI KAISHA (JP) 1991-01-09 — — EP disclosed
Send feedback